These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6117380

  • 1. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
    Shiu MF, Ireland MA, Littler WA.
    Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
    [Abstract] [Full Text] [Related]

  • 2. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R, Meyer J, Schweizer P, Lambertz H, Voelker W, Effert S.
    Acta Med Scand Suppl; 1982 Dec; 659():169-80. PubMed ID: 6127887
    [Abstract] [Full Text] [Related]

  • 3. The immediate haemodynamic and electrophysiological response to prenalterol during fixed rate pacing in patients with chronic ischaemic heart disease.
    Sire S, Amlie JP, Simonsen S.
    Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):43-8. PubMed ID: 3953293
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
    Klein W, Brandt D, Maurer E.
    Clin Cardiol; 1981 Jan; 4(6):325-9. PubMed ID: 6120057
    [Abstract] [Full Text] [Related]

  • 5. Haemodynamic effects of prenalterol in patients with coronary heart disease.
    Hutton I, Murray RG, Boyes RN, Rae AP, Hillis WS.
    Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
    [Abstract] [Full Text] [Related]

  • 6. [Effects of Prenalterol on left ventricular function of coronary patients].
    Javernaro A, Bolognesi R, Giacometti P, Potenza D, Cortesi G, Cucchini F.
    Acta Biomed Ateneo Parmense; 1983 Feb; 54(1):17-8. PubMed ID: 6134412
    [Abstract] [Full Text] [Related]

  • 7. Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation.
    Branzi A, Specchia S, Binetti G, Magelli C, Zannoli R, Magnani B.
    Eur Heart J; 1983 Apr; 4(4):252-8. PubMed ID: 6684041
    [Abstract] [Full Text] [Related]

  • 8. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT, Vatner SF, Braunwald E.
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [Abstract] [Full Text] [Related]

  • 9. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
    Guazzi MD, Qing LG, Olivari MT, Fiorentini C, Loaldi A, Bartorelli A, Moruzzi P, Polese A.
    Acta Med Scand Suppl; 1982 Oct; 659():233-50. PubMed ID: 6127892
    [Abstract] [Full Text] [Related]

  • 10. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
    Muir AL, Hannan WJ, Dewhurst NG, Slessor IM.
    Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483
    [Abstract] [Full Text] [Related]

  • 11. The hemodynamic actions of prenalterol in left ventricular failure.
    Awan NA, Evenson MK, Needham KE, Mason DT.
    Acta Med Scand Suppl; 1982 Oct; 659():251-61. PubMed ID: 6127893
    [Abstract] [Full Text] [Related]

  • 12. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
    Wirtzfeld A, Klein G, Bibra HV, Sauer E.
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
    [Abstract] [Full Text] [Related]

  • 13. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
    Rasmussen S, Høilund-Carlsen PF, Hesse B, Hartling OJ, Fabricius J, Dige-Petersen H, Giese J.
    Eur J Clin Pharmacol; 1984 Jan; 27(5):539-43. PubMed ID: 6151507
    [Abstract] [Full Text] [Related]

  • 14. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
    Kupper W, Schütt M, Bleifeld W.
    Acta Med Scand Suppl; 1982 Jan; 659():287-98. PubMed ID: 6127895
    [Abstract] [Full Text] [Related]

  • 15. [Prenalterol (CGP 7760 B), a new cardioselective beta 1-adrenoceptor-agonist (author's transl)].
    Piepenbrock S, Reichelt W, Zenz M, Seitz W, Sikalieh E.
    Anaesthesist; 1981 Mar; 30(3):118-23. PubMed ID: 6111933
    [Abstract] [Full Text] [Related]

  • 16. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
    Berdeaux A, Bonhenry C, Duhazé P, Giudicelli JF, Thuillez C.
    Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
    [Abstract] [Full Text] [Related]

  • 17. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
    Svendsen TL, Carlsen JE, Hartling OJ, Trap-Jensen J.
    Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
    [Abstract] [Full Text] [Related]

  • 18. Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.
    Pedersen T, Cleemann-Rasmussen K, Brynjolf I, Ording H, Nielsen PE, Rasmussen K.
    Eur J Clin Pharmacol; 1983 Oct; 25(3):287-92. PubMed ID: 6628515
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
    Erbel R, Meyer J, Lambertz H, Schweizer P, Voelker W, Krebs W, Braun G, Effert S.
    Circulation; 1982 Aug; 66(2):361-9. PubMed ID: 6124326
    [No Abstract] [Full Text] [Related]

  • 20. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
    Currie PJ, Kelly MJ, Middlebrook K, Federman J, Sainsbury E, Ashley J, Pitt A.
    Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.